Immunoglobulin M Oligoclonal Bands: Biomarker of Targetable Inflammation in Primary Progressive Multiple Sclerosis
Tarih
2014Yazar
Comabella, Manuel
Jalili, Farzaneh
Leppert, David
de Andres, Clara
Montalban, Xavier
Fernandez, Oscar
Alvarez-Lafuente, Roberto
Masterman, Donna
Garcia-Sanchez, Maria I.
Coret, Francisco
Evdoshenko, Evgeniy
Alvarez-Cermeno, Jose C.
Bar-Or, Amit
Siva, Aksel
Villar, Luisa M.
Casanova, Bonaventura
Ouamara, Nadia
Izquierdo, Guillermo
Arroyo, Rafael
Avsar, Timucin
Lapin, Sergey V.
Johnson, Trina
Üst veri
Tüm öğe kaydını gösterÖzet
Objective: To identify a biomarker distinguishing patients who, despite a primary progressive multiple sclerosis (PPMS) clinical course, may nonetheless benefit from immune therapy.
Koleksiyonlar
- Makale [92796]